Intellectual Property

Life Sciences

Tania A. Shapiro-Barr, Reed R. Heimbecher | Dykema Gossett PLLC

On March 6, 2015, the U.S. Food and Drug Administration (FDA) approved the first biosimilar drug in the U.S., Sandoz’s ZarxioTM, to treat cancer patients who are at increased risk for infection. A “biosimilar” is a biological product that is highly similar to an existing FDA‑...

Intellectual Property

Ansgar C. Rempp | Jones Day

MCC: Please describe the current environment for American law firms doing business in Germany. Rempp: All major challenges that we – and most of the other U.S. firms – faced in Germany have by now been overcome. For instance, some time ago, it was difficult for non-German law firms...

Intellectual Property

John Conroy | Fish & Richardson

MCC: You have recently rejoined Fish in Munich as an American attorney who is admitted to the bar in California and is registered to practice before both the United States Patent and Trademark Office and the European Patent Office. What kind of legal work do you do? Why Munich? Conroy: I help...